Search results
Novartis' (NVS) Sandoz Gets Rights for Stelara Biosimilar
Zacks via Yahoo News· 10 months agoNovartis (NVS) announces an agreement with Samsung Bioepis for exclusive rights to commercialize the...
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo News· 2 months agoSwiss pharma giant Novartis AG NVS reported better-than-expected results for the first quarter of...
Novartis (NVS) to Report Q2 Earnings: Is a Beat in Store?
Zacks via Yahoo News· 12 months agoWhen Novartis (NVS) reports second-quarter 2023 results, investor focus is likely to be on updates...
Novartis (NVS) to Report Q3 Earnings: What's in the Offing?
Zacks via Yahoo News· 9 months agoInvestor focus is likely to be on the top and bottom-line numbers, and updates on guidance...
House Dems press drug companies on nationwide shortages
The Hill via Yahoo News· 5 months agoHouse Oversight Democrats are pressing pharmaceutical companies on the nationwide shortages of a...
What's in Store for Novartis (NVS) This Earnings Season?
Zacks via Yahoo News· 2 years agoInvestors will focus on the regular top and bottom-line numbers along with updates on the Sandoz...
Novartis (NVS) Q4 Earnings Miss on Higher Costs, Sales Lag
Zacks via Yahoo News· 5 months agoSwiss pharma giant Novartis AG NVS reported lower-than-expected results in the fourth quarter of...
Pharma Stock Roundup: NVS to Spin Off Sandoz; JNJ, MRK, ABBV's FDA Updates
Zacks via Yahoo News· 2 years agoNovartis (NVS) plans to spin off its generics division, Sandoz. The FDA approves J&J (JNJ) and...
Novartis (NVS) Tops on Q1 Earnings & Revenues, Ups View
Zacks via Yahoo News· 1 year agoNovartis AG NVS reported strong first-quarter results for 2022. Core earnings (excluding one-time...
Novartis' (NVS) Unit to Acquire Astellas' Rights of Mycamine
Zacks via Yahoo News· 1 year agoNovartis NVS announced that its generic arm, Sandoz, has signed an agreement to acquire worldwide...